| Quarterly Financials | Dec 2020 | Mar 2021 | Jun 2021 | Sept 2021 | Dec 2021 | Mar 2022 | Jun 2022 | Sept 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sept 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sept 2025 | Dec 2025 | Mar 2026 |
Revenue  | 32 | 36 | 120 | 90 | 50 | 96 | 74 | 60 | 47 | 49 | 57 | 34 | 19 | 38 | 20 | 33 | 25 | 18 | 25 | 26 | 19 | 24 |
| Expenses | 31 | 33 | 90 | 70 | 44 | 83 | 62 | 50 | 44 | 50 | 50 | 32 | 21 | 36 | 20 | 31 | 27 | 18 | 24 | 26 | 21 | 21 |
| EBITDA | 2 | 4 | 30 | 20 | 6 | 13 | 12 | 10 | 3 | -1 | 7 | 2 | -2 | 2 | -0 | 3 | -2 | -0 | 1 | 0 | -3 | 3 |
| Operating Profit % | 5 % | 9 % | 25 % | 22 % | 11 % | 13 % | 16 % | 16 % | 6 % | -26 % | 12 % | 5 % | -10 % | 4 % | -9 % | 7 % | -9 % | -4 % | 3 % | 0 % | -14 % | 11 % |
| Depreciation | 0 | 0 | 1 | 1 | 2 | 3 | 2 | 2 | 2 | 3 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 1 | 2 | 2 | 2 | 2 |
| Interest | 1 | 1 | 1 | 2 | 2 | 4 | 3 | 3 | 4 | 2 | 2 | 2 | 3 | 4 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 |
| Profit Before Tax | 1 | 2 | 28 | 17 | 2 | 7 | 7 | 4 | -3 | -6 | 2 | -3 | -6 | -4 | -4 | -1 | -6 | -4 | -3 | -3 | -6 | -1 |
| Tax | 0 | 1 | 8 | 4 | 1 | 2 | 3 | 2 | -1 | -1 | 1 | -0 | -0 | -0 | -1 | 1 | -1 | -2 | -1 | -0 | -1 | 0 |
| Net Profit | 0 | 1 | 20 | 13 | 1 | 5 | 4 | 3 | -2 | -5 | 2 | -2 | -6 | -4 | -3 | -2 | -5 | -2 | -2 | -3 | -5 | -1 |
| EPS in ₹ | 0.42 | 2.30 | 38.66 | 12.41 | 1.29 | 5.16 | 3.99 | 2.20 | -1.36 | -3.63 | 1.41 | -1.74 | -4.52 | -2.75 | -2.35 | -1.53 | -3.98 | -1.56 | -1.52 | -2.24 | -3.60 | -1.07 |
ANG Lifesciences
ANG Lifesciences
30.00
+0.31
(1.04%)
Market Cap
39.21 Cr
PE Ratio
-3.50
Volume
5,814.00
Day High - Low
30.98 - 29.00
52W High-Low
39.70 - 17.63
Key Fundamentals
Market Cap
39.21 Cr
EPS
-8.43
PE Ratio
-3.50
PB Ratio
0.73
Book Value
40.50
EBITDA
0.70
Dividend Yield
0.00 %
Industry
Healthcare Sector
Pharmaceuticals Return on Equity
-19.40
Debt to Equity
1.11
Actual
Company News
View All News
ANG Lifesciences FY26 results
10 days ago
10 days agoANG Lifesciences reported a consolidated loss of ₹1,108.48 lakh for FY26, narrowing from ₹1,241.33 lakh in FY25. Revenue rose to ₹9,289.28 lakh.
ANG Lifesciences Board Meeting on May 30May 22, 2026
May 22, 2026ANG Lifesciences India Limited has scheduled a board meeting on May 30, 2026, to consider the audited financial results for Q4 and FY26.
ANG Lifesciences India Limited disclosed to BSE that it does not fall under the Large Corporate category for FY26, making SEBI borrowing requirements non-applicable to the company.
View more
Peer Comparison Compare Peers on Screener
Competitors | LTP | Market Cap (₹ Cr.) | P/E Ratio | Revenue (₹ Cr.) | YoY Revenue Growth % | Net Profit (₹ Cr.) | YoY Profit Growth % | RSI |
|---|---|---|---|---|---|---|---|---|
1,779.00 | #1 4,26,841.69 | 37.29 | #1 58,220.10 | 6.38 | #1 11,565 | 25.80 | 42.95 | |
6,753.00 | 1,79,270.93 | 67.37 | 10,560.00 | 8.73 | 2,520 | 13.44 | 56.37 | |
4,472.90 | 1,51,383.26 | 69.83 | 13,886.20 | 20.34 | 2,138 | -26.91 | 56.32 | |
1,105.60 | 1,11,249.23 | 21.36 | 26,719.70 | 13.65 | 5,242 | 7.82 | 73.53 | |
1,376.50 | 1,11,191.01 | 29.04 | 29,044.60 | 2.24 | 3,870 | -55.32 | 51.31 | |
1,268.50 | 1,05,874.47 | 25.61 | 33,593.30 | -0.44 | 3,998 | -86.05 | 43.38 | |
2,264.20 | 1,03,483.73 | #1 19.23 | 27,487.50 | 19.98 | 5,345 | #1 87.72 | 46.79 | |
2,391.00 | 98,701.69 | 50.24 | 14,277.60 | 12.03 | 1,750 | 31.75 | 53.06 | |
1,449.00 | 84,158.16 | 24.07 | 33,384.70 | 3.21 | 3,376 | 1.99 | 50.33 | |
1,424.40 | 76,897.17 | 85.23 | 6,812.90 | #1 21.03 | 884 | 21.18 | 70.54 |
Growth Rate
Revenue Growth
-2.12 %
Net Income Growth
4.92 %
Cash Flow Change
97.26 %
ROE
45.86 %
ROCE
-3,352.00 %
EBITDA Margin (Avg.)
-388.46 %
Quarterly Financial Results
Balance Sheet
| Balance Sheet | 2022 | 2023 | 2024 | 2025 | 2026 |
| Total Assets | 291 | 278 | 242 | 230 | 209 |
| Fixed Assets | 93 | 88 | 58 | 57 | 51 |
| Current Assets | 193 | 183 | 173 | 161 | 145 |
| Capital Work in Progress | 0 | 0 | 0 | 0 | 0 |
| Investments | 0 | 0 | 0 | 0 | 46 |
| Other Assets | 198 | 190 | 184 | 172 | 4 |
| Total Equity & Liabilities | 291 | 278 | 242 | 230 | 209 |
| Current Liabilities | 166 | 162 | 145 | 143 | 149 |
| Non Current Liabilities | 41 | 29 | 22 | 22 | 7 |
| Total Equity | 84 | 86 | 76 | 64 | 53 |
| Reserve & Surplus | 69 | 69 | 59 | 46 | 40 |
| Share Capital | 10 | 13 | 13 | 13 | 13 |
Cash Flow
| Cash Flow | 2022 | 2023 | 2024 | 2025 |
| Net Cash Flow | 0 | 0 | 0 | -0 |
| Investing Activities | -44 | -9 | 20 | -2 |
| Operating Activities | 25 | 26 | -10 | -0 |
| Financing Activities | 20 | -17 | -10 | 2 |
Share Holding
| % Holding | Mar 2021 | Sept 2021 | Dec 2021 | Mar 2022 | Jun 2022 | Sept 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sept 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sept 2025 | Dec 2025 | Mar 2026 |
| Promoter | 71.01 % | 71.07 % | 71.09 % | 71.14 % | 71.15 % | 71.15 % | 71.15 % | 70.60 % | 70.60 % | 70.60 % | 70.60 % | 70.60 % | 70.60 % | 70.60 % | 70.60 % | 70.60 % | 70.60 % | 70.60 % | 70.60 % | 70.60 % |
| FIIs | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % |
| DIIs | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % |
| Government | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % | 0.00 % |
| Public / Retail | 19.94 % | 25.53 % | 26.62 % | 25.87 % | 25.66 % | 25.76 % | 25.56 % | 26.13 % | 26.23 % | 26.09 % | 25.29 % | 25.62 % | 25.48 % | 25.45 % | 25.92 % | 26.11 % | 26.11 % | 26.18 % | 26.26 % | 26.21 % |
| Others | 9.05 % | 3.40 % | 2.29 % | 2.99 % | 3.20 % | 3.09 % | 3.30 % | 3.27 % | 3.16 % | 3.31 % | 4.11 % | 3.78 % | 3.92 % | 3.95 % | 3.48 % | 3.29 % | 3.29 % | 3.21 % | 3.13 % | 3.19 % |
| No of Share Holders | 0 | 328 | 323 | 2,522 | 4,259 | 5,215 | 6,939 | 7,163 | 7,305 | 7,055 | 6,918 | 6,868 | 6,631 | 6,468 | 6,517 | 6,508 | 6,400 | 6,273 | 6,084 | 5,952 |
Dividend History
| Annual Cash Flows | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Dividend Per Share (₹) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 1 | 0.00 | 0.00 | 0.00 | 0.00 |
| Dividend Yield (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 1.33 | 0.00 | 0.00 | 0.00 | 0.00 |
Corporate Action
| Record Date | Corporate Action | Information | Announcement Day | LTP at Annoucement | LTP at Record Day |
|---|---|---|---|---|---|
 Bonus | 1:1 | 22 Sept 2021 | 258.12 | 0.00 | |
| 04 Nov 2021 |  Dividend | ₹ 1.00 /share | 02 Nov 2021 | 374.80 | 553.56 |
| 14 Jul 2022 | Bonus | 1:4 | 13 Jul 2022 | 145.32 | 197.70 |
| 30 Sept 2024 |  Annual General Meeting | NA | 30 Sept 2024 | 55.70 | 50.90 |
| 14 Nov 2024 |  Quarterly Result Announcement | NA | 14 Nov 2024 | 46.81 | 44.92 |
| 14 Feb 2025 | Quarterly Result Announcement | NA | 14 Feb 2025 | 41.14 | 38.74 |
| 30 May 2025 | Quarterly Result Announcement | NA | 30 May 2025 | 31.29 | 29.64 |
| 14 Aug 2025 | Quarterly Result Announcement | NA | 14 Aug 2025 | 30.06 | 28.88 |
| 30 Sept 2025 | Annual General Meeting | NA | 30 Sept 2025 | 32.67 | 32.12 |
| 14 Nov 2025 | Quarterly Result Announcement | NA | 14 Nov 2025 | 30.37 | 29.75 |
| 14 Feb 2026 | Quarterly Result Announcement | NA | 14 Feb 2026 | 25.12 | 26.00 |
| 30 May 2026 | Quarterly Result Announcement | NA | 30 May 2026 | 28.97 | 27.31 |
Announcements
Announcement under Regulation 30 (LODR)-Newspaper Publication4 days ago
4 days agoResults - 31.03.202610 days ago
10 days agoBoard Meeting Outcome for Board Meeting Outcome For Audited Financial Results For The Quarter And Year Ended 31St March 202610 days ago
10 days agoCompliances-Reg.24(A)-Annual Secretarial ComplianceMay 29, 2026
May 29, 2026Board Meeting Intimation for Considering The Standalone & Consolidated Audited Financial Results For The Quarter And Year Ended March 31 2026May 22, 2026
May 22, 2026Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure AApr 17, 2026
Apr 17, 2026Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Apr 15, 2026
Apr 15, 2026Clarification On Price Movement In SharesApr 10, 2026
Apr 10, 2026Clarification sought from ANG Lifesciences India LtdApr 10, 2026
Apr 10, 2026Closure of Trading WindowMar 25, 2026
Mar 25, 2026Approval Of Unaudited Financial Results For The Quarter And Nine Months Ended 31-12-2025Feb 14, 2026
Feb 14, 2026Board Meeting Outcome for Approval Of Unaudited Financial Results For The Quarter And Nine Months Ended 31-12-2025Feb 14, 2026
Feb 14, 2026Compliances-Reg.24(A)-Annual Secretarial ComplianceFeb 06, 2026
Feb 06, 2026Board Meeting Intimation for Consideration And Approval Of The Unaudited Standalone And Consolidated Financial Results Of The Company For The Quarter Ended And Nine Months Ended On 31St December 2025.Feb 05, 2026
Feb 05, 2026Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jan 22, 2026
Jan 22, 2026Closure of Trading WindowDec 22, 2025
Dec 22, 2025Unaudited Financial Results For The Quarter And Half Year Ended 30-09-2025Nov 14, 2025
Nov 14, 2025Board Meeting Outcome for Board Meeting Outcome For To Consider And Approve The Financial Results For The Quarter And Half Year Ended 30-09-2025Nov 14, 2025
Nov 14, 2025Board Meeting Intimation for Consideration And Approval Of Unaudited Standalone And Consolidated Financial Results For The Quarter And Half Year Ended On 30Th September 2025.Nov 06, 2025
Nov 06, 2025Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Oct 15, 2025
Oct 15, 2025Shareholder Meeting / Postal Ballot-Scrutinizers ReportOct 01, 2025
Oct 01, 2025Appoitment Of Secretarial AuditorSep 30, 2025
Sep 30, 2025Shareholder Meeting / Postal Ballot-Outcome of AGMSep 30, 2025
Sep 30, 2025Closure of Trading WindowSep 24, 2025
Sep 24, 2025Clarification On Price MovementSep 12, 2025
Sep 12, 2025Clarification Sought from ANG Lifesciences India LtdSep 12, 2025
Sep 12, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationSep 12, 2025
Sep 12, 2025Reg. 34 (1) Annual Report.Sep 06, 2025
Sep 06, 2025Notice Of 19Th AGM Of The Company Scheduled To Be Held On 30Th September 2025Sep 06, 2025
Sep 06, 2025 Intimation Of Book ClosureSep 06, 2025
Sep 06, 202519Th Annual General Meeting (AGM) Of The Shareholders Of The Company Will Be Held On Tuesday The 30Th September 2025 At 11:30 AM Through Video Conference (VC) / Other Audio Visual Means (OAVM)Sep 06, 2025
Sep 06, 2025Board Meeting Outcome for Board Meeting Outcome For Intimation Of AGMSep 06, 2025
Sep 06, 2025Standalone & Consolidated Unaudited Financial Results For The Quarter Ended 30.06.2025.Aug 14, 2025
Aug 14, 2025Board Meeting Outcome for Board Meeting Outcome For Submission Of Standalone And Consolidated Unaudited Financial Results For The Quarter Ended June 30 2025Aug 14, 2025
Aug 14, 2025Board Meeting Intimation for Conducting Board Meeting To Consider And Approve Unaudited Standalone & Consolidated Financial Results For The First Quarter Ended 30Th June 2025.Aug 06, 2025
Aug 06, 2025Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jul 16, 2025
Jul 16, 2025Closure of Trading WindowJun 21, 2025
Jun 21, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationJun 12, 2025
Jun 12, 2025Financial Year Results For The Year Ended 31.03.2025May 30, 2025
May 30, 2025Board Meeting Outcome for Outcome Of Board MeetingMay 30, 2025
May 30, 2025Compliances-Reg.24(A)-Annual Secretarial ComplianceMay 22, 2025
May 22, 2025Board Meeting Intimation for Intimation Of Board Meeting Pursuant To Regulation 29 Of SEBI (Listing Obligation And Disclosure Requirements) Regulation 2015
May 22, 2025
May 22, 2025Disclosure Of Non-Applicability Of SEBI Circular No. SEBI/HO/DDHS/CIR/P/2018/144 Dated 26Th November 2018- Fund Raising By Issuance Of Debt Securities By Large Corporate (LC)
Apr 24, 2025
Apr 24, 2025Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure AApr 24, 2025
Apr 24, 2025Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Apr 22, 2025
Apr 22, 2025Closure of Trading WindowApr 01, 2025
Apr 01, 2025Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeMar 20, 2025
Mar 20, 2025Appointment of Company Secretary and Compliance OfficerMar 12, 2025
Mar 12, 2025Announcement under Regulation 30 (LODR)-Newspaper PublicationFeb 15, 2025
Feb 15, 2025Integrated Filing (Financial)Feb 14, 2025
Feb 14, 2025Technical Indicators
RSI(14)
Neutral 60.01
ATR(14)
Less Volatile 2.43
STOCH(9,6)
Neutral 55.85
STOCH RSI(14)
Overbought 80.87
MACD(12,26)
Bullish 0.08
ADX(14)
Strong Trend 25.02
UO(9)
Bearish 59.49
ROC(12)
Uptrend And Accelerating 8.20
WillR(14)
Neutral -24.53
we are part of Raise Financial Services
built with love
for indians who love to invest & trade
Market Community
Follow us on
